Synthesis and characterization of potential impurities of ezetimibe

被引:0
|
作者
Satheesh, Deekonda [1 ,2 ]
Devi, Dharmasoth Rama [3 ]
Basavaiah, Keloth [2 ]
Sreenivasulu, B. [1 ]
Reddy, Bhavanam Sekhara [1 ]
Aegurla, Balakrishna [1 ]
Kumar, Pallerla Satish [1 ]
Guduri, Anil Kumar [1 ]
Chavakula, Ramadas [1 ]
机构
[1] Aurobindo Pharma Ltd, Chem Res Dept, APL Res Ctr 2, Sangareddy 502329, Telangana, India
[2] Andhra Univ, AU Coll Sci & Technol, Dept Inorgan & Analyt Chem, Visakhapatnam, Andhra Pradesh, India
[3] Dr Sameoul George Inst Pharmaceut Sci, Markapur, India
关键词
API; ezetimibe; des-fluoro aniline analog; ICH; m-fluoro aniline analog; o-fluorobenzene isomer; related substances; REDUCTION; MECHANISM; KETONES;
D O I
10.1002/jhet.4584
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Ezetimibe is an azetidinone derivative and a substituted beta-lactam, it is a hypolipidemic agent, and a drug substance that lowers the cholesterol levels in our body. The present work describes the origin, synthesis, and characterization of three impurities of ezetimibe, which are also positional isomers and/or related substances of ezetimibe. viz: o-Fluoro benzene isomer, m-Fluoro aniline analog, and des-fluoro aniline analogs of ezetimibe.
引用
收藏
页码:318 / 326
页数:9
相关论文
共 50 条
  • [21] Potential Impurities of Tigecycline: Synthesis, Isolation, Characterization and In Vitro Pharmacological Evaluation
    Sharavanan, Selliamman Palaniyandi Nallusamy
    Venkatesan, Chidambaram Subramanian
    Sathiyanarayanan, Singaram
    Kabilan, Senthamaraikannan
    CURRENT PHARMACEUTICAL ANALYSIS, 2020, 16 (06) : 730 - 742
  • [22] Synthesis, structural characterization of optical isomers and potential impurities in Alalevonadifloxacin mesylate
    Kilbile, Jaydeo T.
    Tamboli, Yasinalli
    Ahirrao, Vinod
    Yeole, Ravindra
    Merwade, Arvind Y.
    SYNTHETIC COMMUNICATIONS, 2023, 53 (03) : 234 - 244
  • [23] Synthesis and characterization of potential impurities in key intermediates of Carvedilol: A β-adrenergic receptor
    Suneel Kumar, K.S.
    Tatendra Reddy, K.T.
    Omprakash, G.
    Dubey, P.K.
    Journal of Chemical and Pharmaceutical Research, 2011, 3 (06) : 33 - 45
  • [24] Potential Impurities of the Anti-epileptic Drug, Clobazam: Synthesis and Characterization
    Kumar, Neeraj
    Devineni, Subba Rao
    Bhat, Sandesh
    Aggile, Kadirappa
    Dubey, Shailendra Kumar
    Kumar, Pramod
    LETTERS IN ORGANIC CHEMISTRY, 2017, 14 (10) : 769 - 777
  • [25] Synthesis of Potential Impurities of Bicalutamide
    Bhise, Nandu Baban
    Sathe, Dhananjay Govind
    Radhakrishanan, Tarur
    Deore, Raviraj
    SYNTHETIC COMMUNICATIONS, 2009, 39 (09) : 1516 - 1526
  • [26] Synthesis and characterization of irbesartan impurities
    Satyanarayana, B.
    Anjaneyulu, Y.
    Veerasomaiah, P.
    Reddy, P. Pratap
    HETEROCYCLIC COMMUNICATIONS, 2007, 13 (04) : 223 - 228
  • [27] Identification, synthesis, and characterization of potential genotoxic impurities of sildenafil citrate drug substance
    P. Rajesh Reddy
    Sivanadh Musunuri
    D. Rama Sekhara Reddy
    V. Subrahmanyam Chittala
    V. N. S. Murthy P
    K. Krishnamohan
    Future Journal of Pharmaceutical Sciences, 6
  • [28] Identification, Synthesis, and Characterization of Potential Oxidative Impurities of Venetoclax: Application of Meisenheimer Rearrangement
    Vaddamanu, Guruswamy
    Goswami, Anandarup
    Nandipati, Ravi Shekar Reddy
    Malireddy, Yamini Tanuja
    Reddy, Vinod Kumar Reddy Katam
    Mulakayala, Naveen
    ACS OMEGA, 2023, 8 (41): : 38494 - 38505
  • [29] Identification, synthesis, and characterization of potential genotoxic impurities of sildenafil citrate drug substance
    Rajesh Reddy, P.
    Musunuri, Sivanadh
    Rama Sekhara Reddy, D.
    Chittala, V. Subrahmanyam
    Murthy, V. N. S. P.
    Krishnamohan, K.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
  • [30] Identification and characterization of potential impurities of donepezil
    Reddy, KVSR
    Babu, JM
    Kumar, PA
    Chandrashekar, ERR
    Mathad, VT
    Eswaraiah, S
    Reddy, MS
    Vyas, K
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (05) : 1047 - 1058